Unlock instant, AI-driven research and patent intelligence for your innovation.

Dioxane-modified tetrahydrocarboline-3-formyl-the-edg, its preparation, anti-inflammatory and antithrombotic activities and applications

A technology of dioxane, -the-glu-asp-gly, applied to dioxane-modified tetrahydrocarboline-3-formyl-The-EDG, its preparation, anti-inflammatory and antithrombotic activity and Application areas, able to solve problems such as no substantial progress

Active Publication Date: 2022-06-24
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although great efforts have been made, no substantive progress has been made

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dioxane-modified tetrahydrocarboline-3-formyl-the-edg, its preparation, anti-inflammatory and antithrombotic activities and applications
  • Dioxane-modified tetrahydrocarboline-3-formyl-the-edg, its preparation, anti-inflammatory and antithrombotic activities and applications
  • Dioxane-modified tetrahydrocarboline-3-formyl-the-edg, its preparation, anti-inflammatory and antithrombotic activities and applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Example 1 Preparation of (3S)-1,1-dimethylol-tetrahydro-β-carboline-3-carboxylic acid benzyl ester (1)

[0022] 2 g (7.2 mmol) of L-tryptophan benzyl ester was added to 10 mL of dichloromethane, and the mixture was thoroughly stirred to dissolve. Under ice bath conditions, 1 mL of trifluoroacetic acid was slowly added dropwise to the solution. Then, 0.78 g (8.6 mmol) of 1,3-dihydroxyacetone was added to the solution, and the reaction was carried out at room temperature for 7 hours. TLC showed disappearance of L-tryptophan benzyl ester (dichloromethane / methanol: 30:1). Under ice bath conditions, 50 mL of saturated NaHCO was added to the solution 3 solution, stirred well, and then left a dichloromethane layer, which was then washed with saturated NaHCO 3 The solution (30 mL×3) was washed with saturated NaCl solution (30 mL×3), and the dichloromethane layer was dried with anhydrous sodium sulfate for 12 hours. Filtration and concentration of the filtrate under reduced ...

Embodiment 2

[0023] Example 2 Preparation of 3S-1-(1,1-dimethyl-1,3-dioxane-6-spiroyl)-1,2,3,4-tetrahydro-β-carboline-3- Benzyl Carboxylate (2)

[0024] To 5 mL of anhydrous acetone was added 0.2 g (0.55 mmol) of (3S)-1,1-dimethylol-tetrahydro-β-carboline-3-carboxylic acid benzyl ester (1). In an ice bath, 100 μL of concentrated sulfuric acid was added thereto, followed by stirring at room temperature for 3 hours. TLC showed disappearance of compound 1 (petroleum ether / ethyl acetate, 4:1). in an ice bath with saturated NaHCO 3 The pH value of the reaction solution was adjusted to 7, the obtained solution was concentrated under reduced pressure to remove acetone, the residue was extracted and washed three times with ethyl acetate, and the ethyl acetate layer was washed with saturated NaCl solution until neutral. The ethyl acetate layer was dried over anhydrous sodium sulfate for 12 hours. After filtration, the filtrate was concentrated under reduced pressure to obtain a brownish-yellow ...

Embodiment 3

[0025] Example 3 Preparation of 3S-1-(1,1-dimethyl-1,3-dioxane-6-spiroyl)-1,2,3,4-tetrahydro-β-carboline-3- Carboxylic acid (3)

[0026] To 10 mL of methanol was added 0.20 g (0.5 mmol) of 3S-1-(1,1-dimethyl-1,3-dioxane-6-spiroyl)-1,2,3,4-tetrahydro- Beta-carboline-3-carboxylate benzyl ester (2) and 0.02 g Pd / C. After stirring and passing hydrogen for 12 h, TLC showed disappearance of compound 2 (petroleum ether / ethyl acetate, 4:1). Palladium on carbon (Pd / C) was removed by filtration, and the filtrate was concentrated under reduced pressure. The residue was triturated with ether to give 0.14 g (90%) of the title compound as a colorless solid. ESI-MS(m / e): 317[M+H] + .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses 3S-1-(1,1-dimethyl-1,3-dioxane-6-spiroyl)-1,2,3,4-tetrahydro-β-carboline of the following formula ‑3‑Formyl‑The‑Glu‑Asp‑Gly, discloses its preparation method, and discloses its anti-inflammatory and antithrombotic activities. Its application in the preparation of anti-inflammatory drugs is disclosed.

Description

technical field [0001] The present invention relates to 3S-1-(1,1-dimethyl-1,3-dioxane-6-spiroyl)-1,2,3,4-tetrahydro-β-carboline-3-methyl Acyl-The-Glu-Asp-Gly compound, relates to its preparation method, relates to its anti-inflammatory activity. Therefore, the present invention relates to the application of the compound in anti-inflammatory and antithrombotic drugs. Background technique [0002] 3S-1-(1,1-dimethyl-1,3-dioxane-6-spiroyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid is a A variety of bioactive pharmacophore, theanine is also a pharmacophore with multiple biological activities. In a related invention, the inventors disclose 3S-1-(1,1-dimethyl-1,3-dioxane-6-spiroyl)-1,2,3,4-tetrahydro- 3S-1-(1,1-dimethyl-1,3-dioxane-6-spiro of the following formula left) formed by the fusion of β-carboline-3-carboxylic acid and theanine two pharmacophore groups base)-1,2,3,4-tetrahydro-β-carboline-3-carboxyl-The has antitumor effect. The inventors recognized that in 3S...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/06C07K1/08C07K1/02A61K38/08A61P29/00A61P7/02
CPCC07K7/06A61P29/00A61P7/02A61K38/00
Inventor 赵明彭师奇郤思远
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES